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Brief Clinical Reportsextending into the atrium in 77 of 1122 patients with renal
cancer who underwent radical nephrectomy and complete
tumor thrombectomy between 1970 and 2006 at 11 US
and European institutions.
On the other hand, cardiac metastasis from a renal cell
carcinoma without inferior vena cava extension is rare,
and thus surgical treatment for this condition is also rare.
One study of 11,432 autopsies found only 266 (2.33%)
cardiac tumors, and almost all of themweremetastases orig-
inating from the lung, bone marrow, lymph node, and
kidneys (3/266, 1.1%).2 Another study of 114 autopsies
found metastatic cardiac tumors originating from mela-
noma, germ cell, leukemia, and the kidneys (12/114, 11%).3
Zustovich and colleagues4 reviewed 15 patients who
were surgically treated for cardiac metastasis from renal
cell carcinoma without inferior vena cava involvement.
Their review considered the following as pathologic routes
of metastatic spread: a venous hematogenous pathway
mainly to the right side of the heart and a lymphatic path-
way to the lymph nodes, lungs, pericardium, and left side
of the heart.4 Metastasis to the right side seemed relatively
more frequent, especially to the right ventricle. Among the
15 patients in that review, the right ventricle was involved in
10 of 11 with metastasis to the right side.4
We found only 1 report of a solitary right atrial metastasis
from renal cell carcinoma without inferior vena cava in-
volvement, and this symptomatic patient died shortly after
surgery.5 Because right atrial tumors generally elicit fewFrom the Surgery Department, German Heart Center Munich, Munich, Germany.
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e144 The Journal of Thoracic and Cardiovascular Sursymptoms during the early phase, complete surgical resec-
tion is likely to be difficult. However, an asymptomatic right
atrial tumor that was incidentally detected in our patient
was metastasis that could be resected. This is the first report
of a favorable outcome after complete surgical resection of
a right atrial metastasis from renal cell carcinoma.CONCLUSIONS
Progress in diagnostic imaging allows early diagnosis of
not only symptomatic but also asymptomatic metastatic
cardiac tumors. Surgery should be considered to improve
the prognosis of patients in good condition with such malig-
nancies and to prevent the occurrence of concomitant criti-
cal events.References
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internal thoracic artery–left anterior descending anastomosis: Back
to the future?Domenico Mazzitelli, MD, Nicolo Piazza, Sabine Bleiziffer, and Ruediger Lange, MD, PhD,
Munich, GermanyCoronary artery disease can be identified in up to 50% of
patients undergoing transcatheter aortic valve implantation.
The management of coronary artery disease in patientsundergoing transcatheter aortic valve implantation is cur-
rently a topic of debate. It is currently debated whether
the presence of coronary artery disease or non-
revascularized myocardium is associated with an increased
risk of adverse events in patients undergoing transcatheter
aortic valve implantation.
We report a successful case of concomitant transapical
aortic valve implantation and off-pump revascularization
of the left anterior descending (LAD) artery via a left small
thoracotomy. This procedure, which associates an older
technique with a new one, can be an important hybrid strat-
egy for the concomitant treatment of aortic stenosis and cor-
onary artery disease.gery c September 2011
FIGURE 1. Anterolateral thoracotomy for off-pump coronary artery by-
pass and transapical aortic valve implantation.
FIGURE 2. Coronary angiography showing a patent LITA–LAD bypass
graft and Edwards SAPIENXT valve in situ (Edwards Lifesciences, Irvine,
Calif). LITA-LAD, Left internal thoracic artery–left anterior descending.
Brief Clinical ReportsCLINICAL SUMMARY
An 81-year-old man with low-flow/low-gradient aortic
stenosis presented with New York Heart Association class
IV. Transesophageal echocardiogram revealed a calcified
aortic valve with an effective orifice area of 0.6 cm2,
mean transaortic valve gradient of 30 mmHg, ejection frac-
tion of 20%, and pulmonary artery systolic hypertension
(60 mm Hg). The aortic annulus measured 24 mm. Coro-
nary angiography demonstrated a 90% stenosis at the bifur-
cation of the LAD and first diagonal branch. Furthermore,
the patient had a porcelain aorta identified by a multislice
computed tomography scan. The patient presented with
a history of persistent atrial fibrillation and moderate renal
dysfunction. The patient’s predicted 30-day mortality for
a combined surgical aortic valve replacement and coronary
artery bypass procedure was 30% by logistic European Sys-
tem for Cardiac Operative Risk Evaluation and 33% by
Society of Thoracic Surgeons’ score.
Given the patient’s porcelain aorta and low-flow/low-
gradient aortic stenosis with severe left ventricular dysfunc-
tion (ejection fraction 20%), the possibility of conventional
surgery was rejected. Furthermore, percutaneous revascu-
larization of the LAD diagonal bifurcation was considered
too high risk by the referring cardiologist. After a multidis-
ciplinary team discussion among the cardiac surgeons,
cardiologists, and anesthesiologists, we opted to perform
concomitant off-pump revascularization of the LAD with
the left internal thoracic artery (LITA) and transapical aortic
valve implantation using a 26-mm Edwards SAPIEN XT
transcatheter heart valve (Edwards Lifesciences, Irvine,
Calif).
The procedure was performed in a hybrid operating room
under general anesthesia and double-lumen intubation. A
cardiac surgeon and interventional cardiologist assisted
with the procedure. Via a 6-cm left anterolateral thoracot-
omy, the chest was entered in the fifth intercostal space
(Figure 1). This allowed a perfect exposition of the apex,
but the LAD was too small at this level. Through the
same skin incision, the fourth intercostal space was opened.
The LAD had a diameter of approximately 2 mm. The LITA
was harvested under direct vision using a reusable retractor
(Thoralift, Autosuture, US Surgical Corp, Norwalk, Conn).
The LAD was stabilized with the Octopus system (Med-
tronic, Minneapolis, Minn), and the LITA–LAD anastomo-
sis was completed using a running 7-0 Prolene (Ethicon,
Inc, Somerville, NJ) suture. A flow of 36 mL/min was mea-
sured with a transonic flowmeter.
Transapical aortic valve implantation was subsequently
performed through the fifth intercostal space using
a 26-mm Edwards SAPIEN XT prosthesis (Figure 2). The
technique of transapical transcatheter aortic valve implanta-
tion has been described.1 Postimplantation angiography
showed no aortic regurgitation. Graft patency was alsoThe Journal of Thoracic and Carconfirmed by one selective injection of the LITA graft
(Figure 2). No adverse events occurred postoperatively,
and the patient was transferred to a rehabilitation facility
on postoperative day 14.DISCUSSION
The present case demonstrates the feasibility of perform-
ing minimally invasive off-pump coronary artery bypass
concomitant with transcatheter aortic valve implantation
through the same left anterolateral thoracotomy site.diovascular Surgery c Volume 142, Number 3 e145
Brief Clinical ReportsBecause of the patient’s porcelain aorta and low-flow/
low-gradient severe aortic stenosis (ejection fraction
20%), conventional surgical aortic valve replacement was
denied. Furthermore, the referring cardiologist deemed
percutaneous coronary intervention of the LAD diagonal
bifurcation too high risk. Thus, through the same anterolat-
eral thoracotomy, we opted to perform concomitant off-
pump coronary artery bypass of the LAD artery with the
LITA and transapical aortic valve implantation using
a 26-mm Edwards SAPIEN XT prosthesis. The feasibility
of this approach has been described in only 2 other case
reports.2,3
It is currently debated whether the presence of coronary
artery disease or non-revascularized myocardium is associ-
ated with an increased risk of adverse events in patients
undergoing transcatheter aortic valve implantation.4,5
The described technique is minimally invasive, without
the need of a heart–lung machine and provides the patient
with a coronary artery bypass graft that is known to be
durable. On the other hand, limited operator experience
with off-pump coronary artery bypass surgery and difficul-
ties with locating an adequate thoracotomy site for both
bypass and valve implantation procedure can be potential
challenges.
Minimally invasive off-pump coronary artery bypass sur-
gery was popular in the 1990s. Although the results were
excellent, the rapid growth of 1-vessel percutaneouse146 The Journal of Thoracic and Cardiovascular Surcoronary interventions contributed to a rapid decline of
this technique. Although provocative, it is possible that
once transcatheter aortic valve durability is established,
a combined procedure as described may become an attrac-
tive treatment option for younger patients presenting with
LAD coronary artery disease and severe aortic stenosis.
CONCLUSIONS
The fusion of transcatheter-based procedures and mini-
mally invasive cardiothoracic surgery may provide an alter-
native in those instances when total transcatheter-based
treatment is not possible or may even provide patients
with a minimally invasive treatment associated with more
durable results.
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